In our laboratory we have followed a Research, Development and Point-of-Test of a New Analytical Method. It can provide all oncologists with a valid diagnostic tool to monitor and personalize Tamoxifene treatment.
Based on the epidemiological data and our laboratory experience, Tamoxifene and Endoxifene pharmacological monitoring should become a COMMON PRACTICE in order to guarantee a personalized and effective therapy for all patients.
Why not provide our analytical method to improve the life expectancy of patients and in some cases save their lives? “
This question has been answered by an Italian company sensitive to this specific problem that has decided to engineer the method in the form of ready-to-use KITS.
The Eureka Kit is Simple and Robust and includes everything needed to treat the biological sample and to triple-quadrupole mass spectrometry (LC-MS / MS) analysis.